---
title: Identification and surveillance of rare relapse-initiating stem cells during
  complete remission post-transplantation
date: '2023-12-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38096358/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20231215170556&v=2.18.0
source: Blood
description: Relapse following complete remission (CR) remains the main cause of mortality
  after allogeneic stem cell transplantation for hematological malignancies and therefore
  improved biomarkers for early prediction of relapse remains a critical goal towards
  development and assessment of preemptive relapse treatment. Since the significance
  of cancer stem cells as a source of relapses remains unclear, we investigated whether
  mutational screening for persistence of rare cancer stem cells would ...
disable_comments: true
---
Relapse following complete remission (CR) remains the main cause of mortality after allogeneic stem cell transplantation for hematological malignancies and therefore improved biomarkers for early prediction of relapse remains a critical goal towards development and assessment of preemptive relapse treatment. Since the significance of cancer stem cells as a source of relapses remains unclear, we investigated whether mutational screening for persistence of rare cancer stem cells would ...